Surgical and medical management of small bowel gastrointestinal stromal tumors

Autor: Neeltje Steeghs, Hans Gelderblom, W.T.A. van der Graaf, Pieter A. Boonstra, Sheima Farag, Johannes J. Bonenkamp, F. van Coevorden, Ingrid M.E. Desar, Anna K.L. Reyners, B. van Etten, Dirk J. Grünhagen

Publikováno v: EJSO, 45(3), 410-415. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 45, 410-415
European Journal of Surgical Oncology, 45(3), 410-415. W.B. Saunders
European Journal of Surgical Oncology, 45, 3, pp. 410-415
EJSO-European Journal of Surgical Oncology, 45(3), 410-415. ELSEVIER SCI LTD

Background: A cohort of 201 patients with small bowel gastrointestinal stromal tumors (GIST) treated between January 1st, 2009 and December 31st, 2016 in five GIST expertise centers in the Netherlands was analyzed. Goal of this study was to describe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291373920e32581dd9c1d35fdd00a09f
https://doi.org/10.1016/j.ejso.2018.09.013

Isolated limb perfusion for soft tissue sarcoma: Current practices and future directions. A survey of experts and a review of literature

Autor: M. Fiore, W.J. van Houdt, F. van Coevorden, Chiara Colombo, K.S. Martin-Tellez

Publikováno v: Cancer treatment reviews. 88

Soft tissue sarcomas constitute 1% of adult malignant tumors. They are a heterogeneous group of more than 50 different histologic types. Isolated limb perfusion is an established treatment strategy for locally advanced sarcomas. Since its adoption fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c03a26ff0c70a394b1859c12bf71b9
https://pubmed.ncbi.nlm.nih.gov/32619864

Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer

Autor: Petur Snaebjornsson, R T van der Kaaij, Karolina Sikorska, J P van Kessel, L. E. van der Kolk, J.W. van Sandick, O Balagué, J.M. Van Dieren, Annemieke Cats, F. van Coevorden

Publikováno v: British Journal of Surgery. 105:e176-e182

Background Patients with hereditary diffuse gastric cancer and a CDH1 mutation have a 60–80 per cent lifetime risk of developing diffuse gastric cancer. Total prophylactic gastrectomy eliminates this risk, but is associated with considerable morbid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f53efc4082e0f3da83c1cb9e30f140ad
https://doi.org/10.1002/bjs.10754

Isolated limb perfusion for locally advanced angiosarcoma in extremities

Autor: Henry G. Smith, Dirk J. Grünhagen, Andrew J. Hayes, Robin L. Jones, F. van Coevorden, E.A. Huis in ’t Veld, Cees Verhoef, W.J. van Houdt, A.C.J. van Akkooi

Publikováno v: European Journal of Cancer, 85, 114-121. Elsevier Ltd.

BACKGROUND: Angiosarcomas are rare and aggressive soft-tissue sarcomas. The only potential curative treatment is complete surgical excision. This study reports the outcome of isolated limb perfusion (ILP) with high-dose melphalan and tumour necrosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5694240b2f95a287ac08e7882a7894d
https://doi.org/10.1016/j.ejca.2017.07.023

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Autor: Laurence Brugières, K. Sundby Hall, Bruce Morland, Ioannis Boukovinas, Rolf D. Issels, Sebastian Bauer, D.A. Krakorova, Angela Buonadonna, E. de Álava, Nathalie Gaspar, P. Picci, Palma Dileo, Hans Gelderblom, Bernadette Brennan, Javier Martin Broto, Maria Abbondanza Pantaleo, Paul C Jutte, Ian Judson, Suzanne E. J. Kaal, B. Hassan, Ruth Ladenstein, Alexander Fedenko, Patrick Schöffski, Jean-Yves Blay, A. Le Cesne, Peter Hohenberger, Virginia Ferraresi, Sandra J. Strauss, Michael Montemurro, Robin L. Jones, Peter Reichardt, Stefan S. Bielack, Mikael Eriksson, Stefan Sleijfer, Akmal Safwat, Heikki Joensuu, Rick L. Haas, Bernd Kasper, Hannu T. Aro, Judith V.M.G. Bovée, Jeremy Whelan, A.M. Frezza, Antonio López Pousa, Stefanie Hecker-Nolting, Thomas Brodowicz, R. Biagini, Silvia Stacchiotti, S. Ferrari, Sylvie Bonvalot, S. Piperno-Neumann, Leo Kager, F. van Coevorden, Olga Zaikova, R. Piana, Catharina Dhooge, Piotr Rutkowski, M.H. Robinson, Ofer Merimsky, Katerina Kopeckova, X.G. del Muro, W.T.A. van der Graaf, Paolo G. Casali, N. Abecassis, Eva Wardelmann, Silvia Gasperoni, Giovanni Grignani, A. P. Dei Tos, Andrea Ferrari, Franca Fagioli, Alessandro Gronchi, Thierry Gil, Iwona Lugowska, M. Unk

Publikováno v: Annals of Oncology, 29, iv79-iv95
Annals of Oncology, 29, 79-95. Oxford University Press
Annals of Oncology, 29, 79-95
Annals of Oncology, 29, Supplement_4, pp. iv79-iv95
Annals of Oncology, 29, 79-95. Elsevier Ltd.
ESMO Guidelines Committee, PaedCan and ERN EURACAN 2018, ' Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up ', Annals of Oncology, vol. 29, no. Supplement_4, pp. 79-95 . https://doi.org/10.1093/annonc/mdy310
ANNALS OF ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Digital.CSIC. Repositorio Institucional del CSIC

Primary bone tumours are rare, accounting for < 0.2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and care of cancer patients) database. Different bone tumour subtypes have distinct patterns of i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a742df37d742c9c8b5f3510fae81283
https://hdl.handle.net/1887/96049